Pharmacist Moms Group^™

Richard Kovacs, MD, underscores the pharmacist’s role in educating patients about sodium reduction, monitoring blood pressure, and ensuring safe transitions to low-sodium oxybate therapy.

Two experts discuss sessions that covered perimenopause, premature ovarian insufficiency, GLP-1–based treatments, and the health needs of Indigenous and Hispanic women.

Explore the impact of GLP-1 medication on weight loss in menopausal women, highlighting the need for personalized treatment approaches.

Pharmacists play a crucial role in supporting women through menopause, offering education on treatments, side effects, and long-term health management.

Rajinder Shiwach, MD, MRCPsych, outlines how pharmacists can strengthen retention, patient education, and access to rapid induction strategies for opioid use disorder treatment.

Panelists discuss how unmet needs in early and metastatic breast cancer include overcoming endocrine resistance, improving adverse effect management, ensuring guideline-concordant care, addressing long-term toxicities, and expanding the role of pharmacists in monitoring, clinical trial integration, and advancing the evolving CDK4/6 inhibitor pipeline.

Panelists discuss insights from real-world data on CDK4/6 inhibitor use, including outcomes across diverse populations and clinical settings.

Panelists review key trial data that reinforce the value of CDK4/6 inhibitors in metastatic breast cancer and discuss implications for clinical practice.

Panelists discuss how pharmacists and multidisciplinary teams can empower patients with early or metastatic breast cancer through education, adverse effect management, dose adjustments, frequent follow-up, and integration of CDK4/6 inhibitors with other therapies, while addressing logistical and clinical challenges in practice.